In the latest episode of TIRO’s Voices of Wisdom podcast, Dr. Janice Pasieka hosts Dr. Erik Alexander, a leading endocrinologist from Brigham and Women's Hospital in Boston, to discuss the evolving role of molecular diagnostics in thyroid cancer management. They delve into the types of molecular testing available, particularly Afirma and ThyroSeq version 3, highlighting their diagnostic and prognostic applications for intermediate thyroid nodules. Dr. Alexander shares insights on when to utilize these tests, their impact on clinical decisions, and the significance of understanding molecular signatures in advanced disease. The episode wraps up with Dr. Alexander revealing a hidden gem in Boston offering a unique historical experience for visitors. Feel free to send your questions or suggestions about future episodes to [email protected]. To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related